Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

3ITN

Crystal structure of Pseudo-activated Procaspase-3

Summary for 3ITN
Entry DOI10.2210/pdb3itn/pdb
Related PRD IDPRD_000238
DescriptorCaspase-3, ACETYL-ASP-GLU-VAL-ASP-CHLOROMETHYL KETONE inhibitor (3 entities in total)
Functional Keywordscaspase-3, apoptosis, hydrolase, phosphoprotein, protease, s-nitrosylation, thiol protease, zymogen, hydrolase-hydrolase inhibitor complex, hydrolase/hydrolase inhibitor
Biological sourceHomo sapiens (human)
More
Cellular locationCytoplasm: P42574
Total number of polymer chains2
Total formula weight29168.53
Authors
Walters, J.,Pop, C.,Scott, F.L.,Drag, M.,Swartz, P.D.,Mattos, C.,Salvesen, G.S.,Clark, A.C. (deposition date: 2009-08-28, release date: 2010-03-02, Last modification date: 2023-09-06)
Primary citationWalters, J.,Pop, C.,Scott, F.L.,Drag, M.,Swartz, P.,Mattos, C.,Salvesen, G.S.,Clark, A.C.
A constitutively active and uninhibitable caspase-3 zymogen efficiently induces apoptosis.
Biochem.J., 424:335-345, 2009
Cited by
PubMed Abstract: The caspase-3 zymogen has essentially zero activity until it is cleaved by initiator caspases during apoptosis. However, a mutation of V266E in the dimer interface activates the protease in the absence of chain cleavage. We show that low concentrations of the pseudo-activated procaspase-3 kill mammalian cells rapidly and, importantly, this protein is not cleaved nor is it inhibited efficiently by the endogenous regulator XIAP (X-linked inhibitor of apoptosis). The 1.63 A (1 A = 0.1 nm) structure of the variant demonstrates that the mutation is accommodated at the dimer interface to generate an enzyme with substantially the same activity and specificity as wild-type caspase-3. Structural modelling predicts that the interface mutation prevents the intersubunit linker from binding in the dimer interface, allowing the active sites to form in the procaspase in the absence of cleavage. The direct activation of procaspase-3 through a conformational switch rather than by chain cleavage may lead to novel therapeutic strategies for inducing cell death.
PubMed: 19788411
DOI: 10.1042/BJ20090825
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.63 Å)
Structure validation

226707

数据于2024-10-30公开中

PDB statisticsPDBj update infoContact PDBjnumon